Z-0622-2019Class II
Genesys 1 Reagent, REF 01-03-0020 intended to be used with automated high performance liquid chromatography...
Trinity Biotech USA / initiated 2018-11-01 / Terminated
Clark Laboratories, Inc. (dba,Trinity Biotech USA) began a recall of Genesys 1 Reagent, REF 01-03-0020 intended to be used with automated high performance liquid chromatography (HPLC) systems employing ion exchange... on . FDA classified it as Class II and gives the reason as "lack of 510K". As of , the recall status on record is Terminated.
Recall record
- Recall number
- Z-0622-2019
- Classification
- Class II
- Status
- Terminated
- Initiated
- Posted
- Terminated
- Recalling firm
- Trinity Biotech USA
- Product
- Genesys 1 Reagent, REF 01-03-0020 intended to be used with automated high performance liquid chromatography (HPLC) systems employing ion exchange chromatography. For in vitro diagnostic use only.
- Product code
- GKA Abnormal Hemoglobin Quantitation
- Reason for recall
- lack of 510K
- FDA root cause
- No Marketing Application
- Action
- The firm initiated the recall by letter on 11/01/2018. The letter explained the problem and requested the return of the recalled items.
- Quantity in commerce
- 252 units
- Distribution
- IL, WV, NJ, AZ, MD, UT
- Product codes and lots
- all serial numbers
Enforcement reports
One row per recalled product line| Recall number | Class | Status | Voluntary or mandated | Report date | Classified |
|---|---|---|---|---|---|
| Z-0620-2019 | Class II | Terminated | Voluntary: Firm initiated | ||
| Z-0621-2019 | Class II | Terminated | Voluntary: Firm initiated | ||
| Z-0622-2019 | Class II | Terminated | Voluntary: Firm initiated | ||
| Z-0623-2019 | Class II | Terminated | Voluntary: Firm initiated | ||
| Z-0624-2019 | Class II | Terminated | Voluntary: Firm initiated |
FIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
